共 50 条
- [21] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysisJOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (03) : 203 - 212Jin, ChunhuiZhu, XiaodanHuang, XiaonaGong, TingjieWei, ZhipengYou, Jianliang
- [22] Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysisJOURNAL OF THORACIC DISEASE, 2018, 10 (12) : 6636 - 6652Shen, KaikaiCui, JinggangWei, YuqingChen, XiaojunLiu, GuohuaGao, XiaolaiLi, WeiLu, HuilingZhan, PingLv, TangfengLin, Dang
- [23] A NOVEL CROSS-SITE ANALYSIS OF VECTRA® POLARIS™ MULTIPLEX FLUORESCENCE PD-1/PD-L1 IMMUNOHISTOCHEMISTRY ON COLORECTAL CANCER WITH HIGH AND LOW MICROSATELLITE INSTABILITYJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A58 - A58Pollan, SaraRemeniuk, BethanyHanifi, ArezooRoman, KristinHopkins, BeiMonteiro, NatalieNunns, HarryParnell, ErinnWilliam, JosetteAu, Qingyan
- [24] DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancerClinical Epigenetics, 2018, 10Varun Sasidharan NairSalman M. ToorRowaida Z. TahaHibah ShaathEyad Elkord
- [25] DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancerCLINICAL EPIGENETICS, 2017, 10Nair, Varun SasidharanToor, Salman M.Taha, Rowaida Z.Shaath, HibahElkord, Eyad
- [26] CD8 T CELL REPERTOIRE ANALYSIS OF PATIENTS WITH RESECTABLE HEAD AND NECK CANCER ENROLLED IN A PHASE II NEOADJUVANT STUDY OF a-PD1 ADMINISTERED ALONE OR IN COMBINATION WITH αCTLA4 OR α-LAG3JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A713 - A713Santos, PatriciaKulkarni, AditiLi, HousaiyinChen, JieVujanovic, LazarKim, SeungwonDuvvuri, UmamaheswarZandberg, DanFerris, Robert
- [27] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1 and TIM-3 are markedly increased in basal cell carcinomaTRANSLATIONAL ONCOLOGY, 2022, 19Malinga, Nonkululeko Z.Siwele, Shalete C.Steel, Helen C.Kwofie, Luyanda L., IMeyer, Pieter W. A.Smit, TeresaAnderson, RonaldRapoport, Bernardo L.Kgokolo, Mahlatse C. M.
- [28] Systemic levels of the soluble co-inhibitory immune checkpoints, CTLA-4, LAG-3, PD-1/PD-L1, and TIM-3 are markedly increased in basal cell carcinomaJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Rapoport, Bernardo LeonMalinga, NonkululekoSiwele, ShaleteSteel, Helen C.Kwofie, Luyanda LiMeyer, PieterSmit, TeresaAnderson, RonaldKgokolo, Mahlatse
- [29] Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysisJOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)Guo, MengzhouYuan, FeifeiQi, FengSun, JialeiRao, QianwenZhao, ZhiyingHuang, PeixinFang, TingtingYang, BiweiXia, Jinglin
- [30] Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysisJournal of Translational Medicine, 18Mengzhou GuoFeifei YuanFeng QiJialei SunQianwen RaoZhiying ZhaoPeixin HuangTingting FangBiwei YangJinglin Xia